Skip to content

Q&A Session: TKI Toxicities and Dose Optimisation in CML

Send us your questions –‘Meet-the-CML-Experts’ webinar on May 31st

What are questions from your clinical practice? Do you face any specific challenges? Or do you have a challenging case you would like to have an opinion on?
Take the chance to ask your questions around managing safety issues and TKI toxicities and to discuss strategies for dose optimisation.
Our panel of experts looks forward to answering all your questions that only CML experts can answer.
We welcome all your questions!
1.What is your role regarding CML?
2.In which region do yo live?
3.What are your questions around managing safety issues / TKI toxicities?
Please leave your questions here.
4.What are your questions around strategies for dose optimisation?
Please leave your questions here.
5.Do you have any specific cases on safety issues / TKI toxicities that you like to discuss? Please leave your details here or email to info@cml-foundation.org.
6.Do you have any specific cases on dose optimisation that you like to discuss?
Please leave your details here or email to info@cml-foundation.org.
7.Are you a physician treating CML in a low and middle-income country?
And do you have any specific challenges you like to address?